IMAC HOLDINGS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.21 USD | -5.59% |
|
-20.54% | +45.25% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
IMAC Holdings, Inc. is a clinical research and commercialization company. The Company is focused on innovative medical advancements and care in the oncology, neurological, and orthopedic medical specialties. The Company is focused on providing natural, non-opioid solutions to pain as consumers demand conservative treatments for an aging population. Its Investigational New Drug division conducted a clinical trial for its investigational compound utilizing umbilical cord-derived allogenic mesenchymal stem cells for the treatment of bradykinesia due to Parkinsonâs disease. The Company is also engaged in providing the precision medicine business. The Company's technology, through its patented phosphoprotein and protein biomarker platform and lab developed tests (LDTs), targets multiple areas of oncology and drug development. Its LDTs are utilized by oncologists across the United States to assist in making the targeted treatment plan for their patients with advanced breast cancer.
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
3.4
USD
Average target price
8
USD
Spread / Average Target
+135.29%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +45.25% | 3.9M | |
| -19.34% | 16.51B | |
| +5.41% | 12.53B | |
| +4.64% | 11.74B | |
| +2.21% | 10.06B | |
| +29.17% | 8.71B | |
| -3.46% | 7.57B | |
| +18.60% | 7.14B | |
| +4.93% | 6.68B | |
| +44.78% | 4.54B |
- Stock Market
- Equities
- BACK Stock
- News IMAC Holdings, Inc.
- IMAC Holdings Implements 1-for-30 Reverse Stock Split
